PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
0.06 - 0.07
0.06 - 0.24
4.46M / 3.59M (Avg.)
-1.65 | -0.04
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
43.03%
EBIT growth below 50% of YAL.AX's 106.33%. Michael Burry would suspect deeper competitive or cost structure issues.
43.03%
Positive operating income growth while YAL.AX is negative. John Neff might view this as a competitive edge in operations.
98.33%
Net income growth comparable to YAL.AX's 89.52%. Walter Schloss might see both following similar market or cost trajectories.
98.37%
EPS growth 1.25-1.5x YAL.AX's 87.50%. Bruce Berkowitz would check if strategic initiatives like cost cutting or better capital management explain the difference.
98.37%
Diluted EPS growth 1.25-1.5x YAL.AX's 87.50%. Bruce Berkowitz would verify if strategic moves (e.g., targeted acquisitions, cost cuts) explain the edge.
4.91%
Share count expansion well above YAL.AX's 0.32%. Michael Burry would question if management is raising capital unnecessarily or is over-incentivizing employees with stock.
4.91%
Slight or no buyback while YAL.AX is reducing diluted shares. John Neff might consider the competitor’s approach more shareholder-friendly.
No Data
No Data available this quarter, please select a different quarter.
59.77%
OCF growth 1.25-1.5x YAL.AX's 51.59%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
58.01%
FCF growth similar to YAL.AX's 54.96%. Walter Schloss would attribute it to parallel capital spending and operational models.
-100.00%
Both companies have negative long-term revenue/share growth. Martin Whitman would question if the entire market or product set is shrinking.
-100.00%
Negative 5Y CAGR while YAL.AX stands at 70.47%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-100.00%
Both firms have negative 3Y CAGR. Martin Whitman would wonder if the entire market segment is in short-term retreat.
51.86%
10Y OCF/share CAGR under 50% of YAL.AX's 117.97%. Michael Burry would worry about a persistent underperformance in cash creation.
51.86%
5Y OCF/share CAGR at 75-90% of YAL.AX's 67.53%. Bill Ackman would push for operational improvements to match competitor’s mid-term gains.
51.86%
Positive 3Y OCF/share CAGR while YAL.AX is negative. John Neff might see a big short-term edge in operational efficiency.
98.82%
Net income/share CAGR at 75-90% of YAL.AX's 110.16%. Bill Ackman would press for strategic moves to boost long-term earnings.
98.82%
Below 50% of YAL.AX's 413.54%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
98.82%
Positive short-term CAGR while YAL.AX is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.76%
Asset growth above 1.5x YAL.AX's 11.01%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-1.39%
We have a declining book value while YAL.AX shows 10.04%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-73.75%
We cut SG&A while YAL.AX invests at 109.93%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.